EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

ctDNA as a Dynamic Biomarker to Monitor Immunotherapy Response in KRAS-mutant Non-small Cell Lung Cancer

Ester Munera-maravilla, Judith Carpintero-Basalo, Susana Torres-Martínez, Esther Tercero-Atencia, Marais Mosqueda, Silvia Calabuig-Fariñas, Pablo José Gómez-García, Amaya Fernández-Díaz, Eloisa Jantus-Lewintre, Paula Espinosa Olarte

The Journal of Liquid Biopsy · 2026-11 · 13 · 100511

DOI: 10.1016/j.jlb.2026.100511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Liquid Biopsy, 2026-11. Verfasst von Ester Munera-maravilla und 9 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction: Non-invasive molecular monitoring is increasingly needed to complement tissue-based biomarkers and radiological assessment in advanced non-small cell lung cancer (NSCLC). In patients treated with immune checkpoint inhibitors (ICIs), clinical response remains heterogeneous, and established biomarkers such as PD-L1 do not fully predict therapeutic benefit. Circulating tumor DNA (ctDNA) may capture early changes in molecular tumor burden and improve patient stratification. The prognostic and response-monitoring value of KRAS ctDNA dynamics was therefore evaluated in advanced KRAS-mutant NSCLC treated with first-line ICI-based regimens.

Zitieren

APA

Munera-maravilla, E., Carpintero-Basalo, J., Torres-Martínez, S., Tercero-Atencia, E., Mosqueda, M., Calabuig-Fariñas, S., Gómez-García, P. J., Fernández-Díaz, A., Jantus-Lewintre, E., & Olarte, P. E. (2026). ctDNA as a Dynamic Biomarker to Monitor Immunotherapy Response in KRAS-mutant Non-small Cell Lung Cancer. The Journal of Liquid Biopsy, 13, 100511. https://doi.org/10.1016/j.jlb.2026.100511

Vancouver

Munera-maravilla E, Carpintero-Basalo J, Torres-Martínez S, Tercero-Atencia E, Mosqueda M, Calabuig-Fariñas S, et al. ctDNA as a Dynamic Biomarker to Monitor Immunotherapy Response in KRAS-mutant Non-small Cell Lung Cancer. The Journal of Liquid Biopsy. 2026;13:100511. doi:10.1016/j.jlb.2026.100511

BibTeX
@article{Muneramaravilla2026,
  author = {Munera-maravilla, Ester and Carpintero-Basalo, Judith and Torres-Martínez, Susana and Tercero-Atencia, Esther and Mosqueda, Marais and Calabuig-Fariñas, Silvia and Gómez-García, Pablo José and Fernández-Díaz, Amaya and Jantus-Lewintre, Eloisa and Olarte, Paula Espinosa},
  title = {ctDNA as a Dynamic Biomarker to Monitor Immunotherapy Response in KRAS-mutant Non-small Cell Lung Cancer},
  journal = {The Journal of Liquid Biopsy},
  year = {2026},
  volume = {13},
  pages = {100511},
  doi = {10.1016/j.jlb.2026.100511}
}
Kostenlos starten →